COLUCCI, ROCCHINA LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.749
EU - Europa 888
AS - Asia 584
SA - Sud America 50
OC - Oceania 5
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.280
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.735
IT - Italia 357
CN - Cina 346
FI - Finlandia 217
VN - Vietnam 156
GB - Regno Unito 120
DE - Germania 52
CL - Cile 48
SE - Svezia 43
IE - Irlanda 42
IN - India 15
FR - Francia 13
CA - Canada 12
SG - Singapore 12
TR - Turchia 10
RO - Romania 8
PH - Filippine 7
UA - Ucraina 7
JP - Giappone 6
TW - Taiwan 6
HR - Croazia 5
NL - Olanda 5
PT - Portogallo 5
HK - Hong Kong 4
RU - Federazione Russa 4
AU - Australia 3
ES - Italia 3
ID - Indonesia 3
LB - Libano 3
PK - Pakistan 3
PS - Palestinian Territory 3
RS - Serbia 3
SA - Arabia Saudita 3
TH - Thailandia 3
AT - Austria 2
EG - Egitto 2
MX - Messico 2
NZ - Nuova Zelanda 2
AZ - Azerbaigian 1
BR - Brasile 1
CO - Colombia 1
EU - Europa 1
IQ - Iraq 1
KE - Kenya 1
KR - Corea 1
MK - Macedonia 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 11.280
Salva come PNG Salva come JPEG
Città #
Fairfield 1.976
Woodbridge 1.272
Houston 978
Ann Arbor 970
Ashburn 823
Seattle 708
Cambridge 657
Wilmington 609
Chandler 286
San Diego 203
Medford 189
Princeton 189
Des Moines 153
Dong Ket 152
Padova 141
Beijing 98
Helsinki 89
Nanjing 64
Roxbury 56
Boardman 51
Verona 50
Dublin 41
Shenyang 33
Santiago 32
New York 31
Hebei 28
London 28
Jinan 19
Nanchang 16
Guangzhou 15
Jiaxing 14
Kilburn 11
Borås 10
Ningbo 10
Pescara 10
Phoenix 10
Quilpué 10
Changsha 8
Tianjin 8
Falls Church 7
Milan 7
Pune 7
Serra 7
Treviso 7
Indiana 6
Kharkiv 6
Norwalk 6
Redwood City 6
Tappahannock 6
Buttapietra 5
Campodarsego 5
Chicago 5
Hounslow 5
Mestre 5
San Giórgio Di Nogaro 5
Zagreb 5
Berceni 4
Chorley 4
East Hampton 4
Hanoi 4
Kayseri 4
Montreal 4
New Bedfont 4
New Taipei 4
Piemonte 4
Shanghai 4
Singapore 4
Taizhou 4
Thiene 4
Villa Alemana 4
Zhengzhou 4
Baguio City 3
Beirut 3
Bengaluru 3
Bolzano 3
Chiswick 3
Groningen 3
Hangzhou 3
Islington 3
Lecce 3
Lissone 3
Manila 3
Novi Sad 3
Porto 3
Saint-Martin-d'Hères 3
San Francisco 3
Sydney 3
Tokyo 3
Ankara 2
Ansbach 2
Bangkok 2
Bloomfield 2
Bologna 2
Camerino 2
Camponogara 2
Catania 2
Chaves 2
Davis 2
Delhi 2
Fort Worth 2
Totale 10.283
Salva come PNG Salva come JPEG
Nome #
Effects of a bicarbonate-alkaline mineral water on digestive motility in experimental models of functional and inflammatory gastrointestinal disorders 157
Fibrotic and Vascular Remodelling of Colonic Wall in Patients with Active Ulcerative Colitis 148
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 129
Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity 119
Tu1889 Targeting of NLRP3 Inflammasome With a Novel Selective Inhibitor as a Suitable Strategy for the Pharmacological Treatment of Bowel Inflammation 111
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 110
1077 AMP-Activated Protein Kinase as a Novel Target for the Pharmacological Treatment of Inflammatory Bowel Diseases 108
Impact of Antibiotic-Induced Microbiota Depletion on Small Bowel Excitatory and Inhibitory Neuromuscular Pathways in Adolescent Mice 106
Acetylcholinesterase blockade does not account for the adverse cardiovascular effects of the antitumor drug irinotecan: A preclinical study 105
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy 102
Exploring the genetics of irritable bowel syndrome: A GWA study in the general population and replication in multinational case-control cohorts 101
Mo2044 Irritable Bowel Syndrome, Serotonin Transporter 5HTTLPR Polymorphism and Psychopathological Traits: Dangerous Relations? 100
398 Rifaximin Displays a Protective Activity in Experimental Enteropathy Induced by Indomethacin in Rats 99
Anti-inflammatory effect of a novel locally acting A2Areceptor agonist in a rat model of oxazolone-induced colitis 99
Control of enteric neuromuscular functions by purinergic A3 receptors in normal rat distal colon and experimental bowel inflammation 98
L-histidine decarboxylase decreases its own transcription through downregulation of ERK activity 96
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment 95
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 95
Central administration of cholecystokinin stimulates gastric pepsinogen secretion from anaesthetized rats. 94
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 94
In vitro antiangiogenic activity of selective somatostatin subtype-1 receptor agonists 94
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation 93
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 93
Immunohistochemical Analysis of Myenteric Ganglia and Interstitial Cells of Cajal in Ulcerative Colitis 92
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis 92
H3 receptor-mediated inhibition of intestinal acetylcholine release: pharmacological characterization of signal transduction pathways 91
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 91
Role of peripheral GABAB receptors in the regulation of pepsinogen secretion in anaesthetized rats 91
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 90
Characterization of a novel mechanism accounting for the adverse cholinergic effects of the anticancer drug irinotecan. 89
Histamine H3 receptors mediate inhibition of noradrenaline release from intestinal sympathetic nerves 89
SU2045 Characterization of Excitatory and Inhibitory Neuromuscolar Pathways Regulating Colonic Motility in a Rat Model of Parkinson's Disease 89
Colonic Dysmotility Associated with High Fat Diet-Induced Obesity: Role of the Enteric Glia 89
Aging Modulates the Influence of Arginase on Endothelial Dysfunction in Obesity 89
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 89
Effects of L-DOPA/Benserazide Co-Treatment on the Patterns of Colonic Neuromuscular Excitatory Cholinergic and Tachykininergic Pathways in the Presence of Experimental Parkinson's Disease 88
Mo1810 Cyclooxygenase Inhibitors Counteract PRO-Fibrotic Signalling in Experimental Colitis Through Modulation of TGF-Beta/SMAD Network 88
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 86
Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon 86
Microvascular Endothelial Dysfunction in Patients with Obesity 86
Su2089 Fibrotic Remodelling and Damage of the Colonic Neuromuscular Compartment in the Presence of Bowel Inflammation 85
Role of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice 84
PACAP and gastrin regulate the histidine decarboxylase promoter via distinct mechanisms 83
The β3-adrenoceptor agonist SR58611A ameliorates experimental colitis in rats 83
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 83
Goodman & Gilman. Le basi farmacologiche della terapia. Con espansione online 83
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 83
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon 82
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 82
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 81
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction 81
Colonic Dysmotility Associated With High Fat Diet-Induced Obesity: Involvement of Endogenous Adenosine via a2B Receptors 81
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy 81
A 2,3-diphenylpyrido[1,2-a] pyrimidin-4-one derivative inhibits specific angiogenic factors induced by TNF-alpha 81
Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis 80
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases 79
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 79
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 79
The ecto-enzymes CD73 and adenosine deaminase modulate 5′-AMP-derived adenosine in myofibroblasts of the rat small intestine 79
CCK-1 and CCK-2 receptors regulate gastric pepsinogen secretion 79
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing 78
Gastric motor dysfunctions in Parkinson's disease: Current pre-clinical evidence 78
Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage 77
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 77
Sa1702 Alterations of Colonic Neuromuscular Excitatory Tachykininergic Pathways in a Mouse Model of Diet Induced-Obesity 77
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders 76
Altered expression pattern of molecular factors involved in colonic smooth muscle functions: an immunohistochemical study in patients with diverticular disease 76
Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds 76
Sa1694 Colonic Inflammation in Experimental Parkinson's Disease: Evidence of Altered Colonic Tachykininergic Neurotransmissio 76
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review 76
Central GABA-A receptors exert a tonic inhibitory control on gastric pepsinogen secretion in anaesthetized rats 75
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 75
Involvement of the P2X7 Purinergic Receptor in Colonic Motor Dysfunction Associated with Bowel Inflammation in Rats. 74
Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? 74
Adenosine and inflammation: what's new on the horizon? 72
W1720 Effects of Proton Pump Inhibitors on Healing of NSAID-Induced Gastric Ulcerations in the Presence of a Continued NSAID Treatment: Characterization of Molecular Mechanisms 72
Inducible nitric oxide synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats 70
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models 70
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 70
Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications 69
Inhibition of adenosine deaminase attenuates inflammation in experimental colitis 68
Su1193 Rifaximin Prevents Enteric Bacteria Alterations and Inflammation in a Rat Model of Diclofenac-Induced Enteropathy 68
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 68
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 68
Ghrelin restores nitric oxide availability in resistance circulation of essential hypertensive patients: role of NAD(P)H oxidase 68
Effects of pantoprazole on ulcer healing delay associated with NSAID treatment 67
Adenosine pathway and cancer: Where do we go from here? 67
Alterations of Colonic Neuromuscular Excitatory Cholinergic Pathway in a Rat Model of 6-Hydroxydopamine-Induced Parkinson's Disease 67
Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 down-regulation 67
Cholinergic toxic syndrome by the anticancer drug irinotecan: acetylcholinesterase does not play a major role 66
Effects of L-DOPA/Benserazide Co-Treatment on Colonic Dysmotility and Enteric Inflammation Following Dopaminergic Nigrostriatal Neurodegeneration 66
A holistic view of adenosine pathways in the control of intestinal neuromuscular functions: the enteric purinome concept 66
Effects of maternal obesity and direct exposure to high-fat diet on bowel functions in offsprings 66
Somatostatin modulates both cyclooxygenase-2 expression and proliferation in human colon cancer cells 65
Microvascular endothelial dysfunction in human obesity: role of TNF-α 64
Role of cyclooxygenase-2 in the proliferative activity of gastrin on human colon cancer cells 63
Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage 61
Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration 61
Pharmacological modulation of adenosine receptor pathways and inflammatory disorders: the way towards novel therapeutics? 60
Su2049 Involvement of the P2X7 Purinergic Receptor in Colonic Motor Dysfunction Associated With Bowel Inflammation in Rats 60
Totale 8.383
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.345
article - articoli 38.014
book - libri 162
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 716
Totale 79.237
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.017 0 0 0 0 0 0 0 0 0 218 439 360
2019/20202.546 292 89 42 230 274 176 302 316 326 256 164 79
2020/20212.239 120 95 110 130 67 461 87 151 410 136 207 265
2021/20222.178 62 181 346 182 94 105 86 265 137 52 187 481
2022/20231.045 326 27 10 75 211 123 14 71 116 9 39 24
2023/2024522 33 62 63 64 68 48 47 47 25 65 0 0
Totale 11.633